Status:
COMPLETED
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This 6 arm study will evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of multiple doses and regimens of a GLP-1 analogue in patients with type 2 diabetes who are treated with a st...
Eligibility Criteria
Inclusion
- adult patients, 18-75 years of age;
- type 2 diabetes mellitus, with stable metformin treatment for \>=3 months;
- stable weight +/-10% for \>=3 months before screening.
Exclusion
- type 1 diabetes mellitus;
- treatment with any anti-hyperglycemic medication other than metformin monotherapy during last 3 months;
- use of weight-lowering medications in the last 3 months;
- uncontrolled hypertension.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT00423501
Start Date
February 1 2007
End Date
November 1 2007
Last Update
November 2 2016
Active Locations (49)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington D.C., District of Columbia, United States, 20010
2
Woodstock, Georgia, United States, 30189
3
Chicago, Illinois, United States, 60607
4
Springfield, Illinois, United States, 62704-1433